Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/17662
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Type: Journal article
Title: Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry
Author: Callaghan, P.
Irvine, R.
Daws, L.
Citation: Neurochemistry International, 2005; 47(5):350-361
Publisher: Pergamon-Elsevier Science Ltd
Issue Date: 2005
ISSN: 0197-0186
Statement of
Responsibility: 
Paul D. Callaghan, Rodney J. Irvine and Lynette C. Daws
Abstract: Illicit use of p-methoxyamphetamine (PMA) is rapidly increasing. However, little is known about the acute effects of PMA on neurotransmission in vivo. High-speed chronoamperometry was used to monitor neurotransmitter release and clearance in anesthetized rats after local application of PMA or 3,4-methylenedioxymethamphetamine (MDMA). In striatum, PMA caused less neurotransmitter release than MDMA. PMA-evoked release could be partially blocked by pre-treatment with a serotonin (5-HT) reuptake inhibitor, suggesting that evoked 5-HT release contributed to the electrochemical signal and was mediated by the 5-HT transporter (SERT). MDMA-evoked release was not blocked by a SERT inhibitor, suggesting that primarily DA was released. To study the effect of these amphetamines on clearance of 5-HT mediated specifically by the SERT, clearance of exogenously applied 5-HT was measured in the CA3 region of the hippocampus. In contrast to the striatum where 5-HT is cleared by both the SERT and the dopamine transporter (DAT), 5-HT is cleared primarily by the SERT in the CA3 region. This is also a region where neither PMA nor MDMA evoked release of neurotransmitter. The maximal inhibition of 5-HT clearance was greater after PMA than MDMA. These data demonstrate in vivo (1) brain region variability in the ability of PMA and MDMA to evoke release of neurotransmitter; (2) that clearance of 5-HT in the striatum is mediated by both the SERT and the DAT; (3) distinct differences in the amount and nature of neurotransmitter released in the striatum after local application of PMA and MDMA and (4) that PMA is a more efficacious inhibitor of 5-HT clearance in the hippocampus than MDMA. These fundamental differences may account for the more severe adverse reactions seen clinically after PMA, compared to MDMA.
Keywords: Para-methoxyamphetamine; 3,4-Methylenedioxymethamphetamine; Serotonin transporter; Dopamine transporter; chronoamperometry; Release; uptake
RMID: 0020050754
DOI: 10.1016/j.neuint.2005.04.026
Description (link): http://www.elsevier.com/wps/find/journaldescription.cws_home/643/description#description
Appears in Collections:Pharmacology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.